Invention Grant
- Patent Title: Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
-
Application No.: US15348842Application Date: 2016-11-10
-
Publication No.: US09669040B2Publication Date: 2017-06-06
- Inventor: Herriot Tabuteau
- Applicant: ANTECIP BIOVENTURES II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: K&L Gates LLP
- Agent Brent A. Johnson; Louis C. Cullman
- Main IPC: A61K31/66
- IPC: A61K31/66 ; A61K31/415 ; A61K31/675 ; C07F9/58 ; C07F9/6506 ; C07F9/6561 ; C07D233/60 ; C07F9/38 ; A61K9/20 ; A61K9/00
Abstract:
Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions such as complex regional pain syndrome.
Public/Granted literature
Information query
